Niles Medical Evaluation Bakersfield, CA - 93305

Niles Medical Evaluation is categorized under Concert Management Services in Bakersfield, CA and active since 2006.

Niles Medical Evaluation was established in 2006, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Concert Management Services business, which does work in the B2B market, and is classified as a Concert Management Services, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Andreas Juharyan at the company’s single location by writing to 2128 Niles St, Bakersfield, California CA 93305 or by phoning (661) 328-6200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Niles Medical Evaluation
Contact Person: Andreas Juharyan
Address: 2128 Niles St, Bakersfield, California 93305
Phone Number: (661) 328-6200
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Concert Management Services
SIC Code: 7922
NAICS Code: 6214930
Share This Business:

Niles Medical Evaluation was started in 2006 to provide professional Concert Management Services under the SIC code 7922 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Andreas Juharyan for inquiries that concern Niles Medical Evaluation by calling the company number (661) 328-6200, as your correspondence is most welcome. Additionally, the physical location of the single location of Niles Medical Evaluation can be found at the coordinates 35.37661,-118.96816 as well as the street address 2128 Niles St in Bakersfield, California 93305.

For its online presence, you may visit Niles Medical Evaluation’s website at and engage with its social media outlets through on Twitter and on Facebook.